Form 4: Predictive Oncology Director Receives Stock Grant
Insider Transaction (Form 4)
Thorsten Dirks, a Director of Predictive Oncology Inc., reported multiple transactions in common stock on April 20, 2026.
Summary
- Grant/award: acquired 5,144 Common Stock on April 20, 2026; holds 5,144 after (Direct).
- Grant/award: acquired 2,420 Common Stock on July 1, 2026; holds 7,564 after (Direct).
- Grant/award: acquired 733 Common Stock on October 1, 2026; holds 8,297 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Thorsten Dirks — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-04-20 | Grant/award | Common Stock | 5,144 | — | — | 5,144 |
| 2026-07-01 | Grant/award | Common Stock | 2,420 | — | — | 7,564 |
| 2026-10-01 | Grant/award | Common Stock | 733 | — | — | 8,297 |
Key Dates
| Date | Description |
|---|---|
| 2026-04-20 | Grant/award (5,144 shares) |
| 2026-07-01 | Grant/award (2,420 shares) |
| 2026-10-01 | Grant/award (733 shares) |
Keywords
insider transaction, Form 4, AGPU, Axe Compute Inc., neutral, Thorsten Dirks
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.